deltatrials
Completed OBSERVATIONAL NCT03876379

Brain Power Spectral Density Under Propofol (PROBRAIN)

Brain Power Spectral Density Under Propofol and Its Association With Cerebral Fragility, an Objective Means to Estimate the Probability of Presenting Burst Suppression

Sponsor: INSERM UMR-942, Paris, France

Updated 4 times since 2019 Last updated: Mar 13, 2019 Started: Jan 24, 2015 Primary completion: Jan 5, 2016 Completion: Jan 5, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Interventional and Orthopedic Surgery, this trial is completed. The trial is conducted by INSERM UMR-942, Paris, France and has accumulated 4 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Apr 2019 – ~Jan 2021 · 21 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Apr 2019 — Jan 2021 [monthly]

    Completed

    First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • INSERM UMR-942, Paris, France
  • Joaquim MATEO
  • M3DISIM
Data source: Hopital Lariboisière

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.